Endocrine cells in rectal biopsy specimens from patients with familial amyloidotic polyneuropathy

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 1, 1996, Pages 68-73

  El Salhy, M ^a   Suhr, O ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Familial amyloidosis; Immunocytochemistry; Morphometry; Pancreatic polypeptide; Rectum; Serotonin

Indexed keywords

CHROMOGRANIN A; OXYNTOMODULIN; PANCREAS POLYPEPTIDE; PEPTIDE YY; SEROTONIN; SOMATOSTATIN;

ADULT; AGED; AMYLOID NEUROPATHY; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONSTIPATION; CONTROLLED STUDY; ENDOCRINE CELL; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MORPHOMETRICS; PRIORITY JOURNAL; RECTUM BIOPSY;

EID: 0030045129     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609031629     Document Type: Article

References (40)

1. 30-gene in two Swedish sibs with familial amyloidotic polyneuropathy. Clin Genet 1988;23:333-8.
2. Saraiva M, Costa P, Burken S, Goodman D. Pre-schooler of an abnormal transthyretin in Portuguese patients with amyloidotic polyneuropathy. Trans Assoc Am Phys 1983;96:261-70.
3. Tawara S, Nakazato M, Kanagawa K, Matsuo, H, Akari S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983;116:880-8.
4. Dwulet F, Benson M. Polymorphism of human plasma thyroxin binding prealbumin. Biochem Biophys Res Commun 1983;114: 657-62.
5. Staunton H, Dervan P, Kale R, Linke RP, Kelly P. Hereditary amyloid polyneuropathy in north west Ireland. Brain 1987; 110:1231-45.
6. Chang CM, Yu YI, Wong M, Woo E, Haung CY. Type I familial amyloid polyneuropathy in Chinese family. Acta Neurol Scand 1989;79:391-6.
7. Feurle G. Pathophysiology of diarrhoea in patients with familial amyloid neuropathy. Digestion 1987;36:13-7.
8. Holt IJ, Harding AE, Middletton L, Chrysostomou G, Said G, King RH, et al. Molecular genetics of amyloid neuropathy in Europe. Lancet 1989;1:524-6.
9. Andersson O. Familial amyloidosis with polyncuropathy: A clinical study based on patients living in northern Sweden. Acta Med Scand 1976; 198 Suppl 590:1-64.
10. Olofsson B-O. Cardiac involvement in familial amyloidosis with polyneuropathy. Int J Cardiol 1983;4:71-3.
11. Steen L, Ek B. Familial amyloidosis with polyneuropathy. A long term follow up of 21 patients with special reference to gastrointestinal symptoms. Acta Med Scand 1984;214:387-97.
12. Suhr O, Danielsson A, Steen L. Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of patients with familial amyloidosis with polyneuropathy. Scand J Gastroenterol 1992;27:201-7.
13. Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Int Med 1994;235:479-85.
14. 30). Clin Genet 1991;40:242-6.
15. Holmgren G, Ericksson B-G, Groth C-G, Suhr O, Steen L, Andersson O, et al. Clinical benefit and regression of amyloidosis following liver transplantation in patients with familial amyloid polyneuropathy due to transthyretin variant Met-30. Lancet 1993;341:1113-6.
16. Dehas TH, Mulvihill SJ. Neuroendocrine design of the gut. Am J Surg 1991;161:243-9.
17. Ekblad E, Håkansson R, Sundler F. Microanatomy and chemical coding of peptides-containing neurone in the digestive tract. In: Daniel E, editor. Neuropeptides function in gastrointestinal tract. Boston: CRC Press, Inc, 1990:131-80.
18. Harvey RF. Hormonal control of gastrointestinal motility. Am J Dig Dis 1975;20:523-9.
19. Allescher H, Ahmed S. Postulated physiological and pathophysiological roles on motility. In: Daniel E, editor. Neuropeptides function in gastrointestinal tract. Boston. CRC Press, Inc, 1990:309-400.
20. Rangachari PK. Effects of neuropeptides on intestinal ion transport. In: Daniel E, editor. Neuropeptides function in gastrointestinal tract. Boston: CRC Press, Inc, 1990:429-46.
21. El-Salhy M, Suhr O, Stenling R, Wilander E, Grimelius L. Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut 1994;35:1413-8.
22. Sjölund K, Sandén G, Håkansson R, Sundler F. Endocrine cells in human intestine. An immunocytochemical study. Gastroenterology 1983;8:1120-30.
23. Calam J, Ghatei MA, Domin J, Adrian TE, Myszor M, Gupta S, et al. Regional differences in concentrations of regulatory peptides in human colon mucosal biopsy. Dig Dis Sci 1989; 34:1193-8.
24. Southern E. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98:503-17.
25. Holmgren G, Holmberg F., Lindström A, Lindström E, Nordenson I, Sandgren O, et al. Diagnosis of familial amyloidotic polyneuropathy in Sweden by RFLP analysis. Clin Genet 1988;33:176-80.
26. Steen L, Ek BO. Familial amyloidosis with polyneuropathy. Aspects of relationship between gastrointestinal symptoms. EMO findings, and malabsorption studies. Scand J Gastroenterol 1984;19:480-6.
27. Sjölund K. Gut neurohormonal peptides in health and disease [PhD Thesis]. Lund, Sweden: University of Lund, 1982.
28. Lehy T, Peranzi G, Cristina ML. Correlating immunocytochemical and electron microscopic studies: Identification of entero (glucagon)-, somatostatin-, and pancreatic polypeptide-like containing cells in the human colon. Histochemistry 1981;71: 67-80.
29. Solicia E, Buffa R, Capella C, Fiocca R, Fontana P, Crivelli O. Immunohistochemical characterization of gastroenteropancreatic endocrine cells and related multihormonal cells. Problem, pitfalls and facts. In: Myoshi A, editor. Gut peptides: secretion, function, and clinical aspects. Amsterdam: Elsevier Biomedical Press, 1979:303-9.
30. El-Salhy M, Grimelius L, Wilander E, Ryberg B, Terenius L, Lundberg JM, et al. Immunocytochemical identification of polypeptide YY (PYY) in the human gastrointestinal tract. Histochemistry 1983;77:15-23.
31. El-Salhy M, Grimelius L. Immunocytochemical demonstration of polypeptide YY (PYY) in the gastrointestinal tract of the monkey, Macaca rhesus: a light and electron microscopic study. Biomed Res 1983;4:289-94.
32. Huizinga JD, Pintin-Quezada J. Physiological and pathophysiological roles of VIP, somatostatin, opioids, galanin, GRP, and secretin. In: Daniel O, editor. Neuropeptides function in gastrointestinal tract. Boston: CRC Press, Inc, 1990:401-28.
33. Gaff JJ, Martin WR. Opioid analgesics and antagonists. In: Gilman, AG, Goodman LS, Rall TW, Murad F, editors. Pharmacological basis of therapeutics. 7th ed. New York: Macmillan, 1985:491-503.
34. Stewart JJ. Temporal effects of morphine on rat intestinal transit. Pharmacology 1984;29:47-54.
35. Plant OH, Miller GH. Effect of morphine and some other opium alkaloids on the muscular activity of the alimentary canal. J Pharmacol Exp Ther 1926;28:245-52.
36. Blanquet F, Bouvier M, Conella J. Effects of enkephalins and morphine on spontaneous electrical activity and on junction potentials elicited by parasympathetic nerve stimulation in cat and rabbit colon. Br J Pharmacol 1982;77:419-26.
37. Schang JC, Hemond M, Herbert M, Pilote M. How does morphine work on colonie motility? An electromyographic study in the human left and sigmoid colon. Life Sci 1986;38: 671-5.
38. Adrian TK, Greenberg GR, Bloom SR. Actions of pancreatic polypeptide in man. In: Bloom SR, Polak JM, editors. Gut hormones. Edinburgh: Churchill Livingstone, 1981:206-12.
39. McDonald. Gastroentropancreatic regulatory peptide structure: An overview. In: Daniel E, editor. Neuropeptides function in gastrointestinal tract. Boston: CRC Press, Inc. 1990:19-86.
40. Lin TM, Evans DC:, Shaar CJ, Chance RE. Physiological versus pharmacological actions of bovine pancreatic polypeptide on the pancreas, gallbladder, choledochal sphincter and intestine of dogs. In: Myoshi A, editor. Gut peptides: secretion, function, and clinical aspects. Amsterdam: Elsevier Biomedical Press, 1979:175-81.